Want to see TSE:CNO full AI Analyst Report?
Top Page
California Nanotechnologies
(CNO)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.34
▲(10.00% Upside)
Action:Reiterated
Date:08/01/26
The score is primarily held back by weak financial performance, with heavy losses and negative operating/free cash flow despite modest revenue growth. Technicals are mixed (below 20D/200D but above 50D/100D), offering only limited support. Valuation is also constrained because the negative P/E reflects unprofitability and there is no dividend yield.
Positive Factors
Specialized advanced-materials processing model
The company serves applications requiring controlled particle size, composition, and microstructure, giving its materials and processing capabilities relevance in specialized manufacturing workflows. This focused model can support recurring customer development and production opportunities across additive and powder-based applications.
Negative Factors
Deeply negative profitability
The company is currently unable to convert positive gross profit into sustainable operating or net earnings. Deep losses reduce internally generated funding for growth, expose the business to adverse cost or pricing changes, and make future performance dependent on a meaningful improvement in operating economics.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized advanced-materials processing model
The company serves applications requiring controlled particle size, composition, and microstructure, giving its materials and processing capabilities relevance in specialized manufacturing workflows. This focused model can support recurring customer development and production opportunities across additive and powder-based applications.
Read all positive factors
California Nanotechnologies (CNO) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$16.37M
Dividend YieldN/A
Average Volume (3M)22.81K
Price to Earnings (P/E)―
Beta (1Y)2.65
Revenue Growth-42.97%
EPS Growth-34.24%
CountryCA
Employees20
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.04
Shares Outstanding46,764,660
10 Day Avg. Volume23,174
30 Day Avg. Volume22,809
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)5.15
Price to Sales (P/S)3.59
P/FCF Ratio-23.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.04
Revenue Forecast (FY)C$3.27M
California Nanotechnologies Business Overview & Revenue Model
Company Description
California Nanotechnologies Corp. is dedicated to the research, advancement, and manufacturing of nanocrystalline materials, primarily achieved through the reduction of grain size. The company offers a comprehensive array of advanced material proc...
How the Company Makes Money
CNO makes money primarily by selling materials and charging for processing/manufacturing services associated with producing and refining advanced metal/alloy powders. Key revenue streams include: (1) materials sales—revenue from supplying nanostru...
California Nanotechnologies Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
47
Neutral
Cash Flow
28
Negative
| Breakdown | May 2026 | May 2025 | May 2024 | May 2022 | May 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.83M | 6.22M | 3.34M | 1.82M | 1.06M |
| Gross Profit | -610.56K | 4.59M | 2.33M | 669.57K | 439.97K |
| EBITDA | -1.32M | 780.97K | 753.02K | 337.91K | 10.77K |
| Net Income | -1.89M | -158.33K | 381.68K | 79.76K | -161.40K |
Balance Sheet | |||||
| Total Assets | 3.88M | 5.50M | 2.36M | 1.41M | 587.40K |
| Cash, Cash Equivalents and Short-Term Investments | 207.00K | 533.85K | 841.35K | 294.13K | 25.29K |
| Total Debt | 1.31M | 1.62M | 1.21M | 1.94M | 1.94M |
| Total Liabilities | 1.90M | 3.19M | 2.21M | 2.70M | 2.24M |
| Stockholders Equity | 1.98M | 2.32M | 145.97K | -1.29M | -1.66M |
Cash Flow | |||||
| Free Cash Flow | -439.56K | 797.00K | 89.98K | 604.26K | 33.20K |
| Operating Cash Flow | -388.46K | 2.92M | 104.28K | 717.01K | 33.20K |
| Investing Cash Flow | -51.11K | -2.11M | -14.30K | -112.75K | 0.00 |
| Financing Cash Flow | 107.53K | -1.12M | 535.33K | -387.83K | -62.52K |
California Nanotechnologies Technical Analysis
Positive
0.31
Price Trends
0.32
Positive
0.29
Positive
0.30
Positive
Market Momentum
<0.01
Negative
65.99
Neutral
55.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Positive. The current price of 0.31 is above the 20-day moving average (MA) of 0.31, below the 50-day MA of 0.32, and above the 200-day MA of 0.30, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 65.99 is Neutral, neither overbought nor oversold. The STOCH value of 55.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CNO.
California Nanotechnologies Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
57 Neutral | C$202.15M | -24.54 | -5.06% | 1.88% | 6.10% | -46.82% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | C$299.17M | -11.18 | -475.00% | ― | 77.39% | -226.10% | |
47 Neutral | C$103.01M | -6.12 | -81.75% | ― | ― | -42.93% | |
45 Neutral | C$16.37M | -6.47 | -76.50% | ― | -42.97% | -34.24% | |
44 Neutral | C$6.09M | -6.09 | -24.00% | ― | ― | -904.55% |
* General Sector Average
TSE:CNO
California Nanotechnologies
0.35
0.02
6.06%
TSE:BOS
Airboss of America
7.44
2.51
50.94%
TSE:NANO
Nano One Materials
0.86
0.00
0.00%
TSE:GMG
Graphene Manufacturing Group Ltd
2.38
1.61
209.09%
TSE:SURE
SureNano Science Ltd
0.15
0.04
45.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.